Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (178)

1

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Harvey-Jones, E. | Raghunandan, M. | Robbez-Masson, L. | +36

2

Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment

enthalten in: Cancer letters | 2024

von Madorsky Rowdo, F. | Xiao, G. | Khramtsova, G. | +23

UpdateOf: bioRxiv. 2023 Jun 22;:. - PMID 38076873

3

Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer

enthalten in: Gynecologic oncology | 2024

von Kim, J. | Kim, S. | Park, E. | +5

4

Clinical response of pancreatic cancer bearing a germline BRCA2 p.I3169M fs*48 variant for platinum-based drug and PARP inhibitor

enthalten in: Japanese journal of clinical oncology | 2024

von Akahira, R. | Fukuda, K. | Shimazu, K. | +5

5

Germline BRCA2 variant with low variant allele frequency detected in tumor-only comprehensive genomic profiling

enthalten in: Cancer science | 2024

von Hayashi, H. | Kunimasa, K. | Tanishima, S. | +6

6

BRCA1/2 reversion mutations in a pan-cancer cohort

enthalten in: Cancer science | 2024

von Nakamura, K. | Hayashi, H. | Kawano, R. | +20

7

Targeting the DNA repair pathway for breast cancer therapy : Beyond the molecular subtypes

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Qu, Y. | Qin, S. | Yang, Z. | +11

8

The Sensitization of Triple-Negative Breast Cancers to Poly ADP Ribose Polymerase Inhibition Independent of BRCA1/2 Mutation Status by Chemically Modified microRNA-489

enthalten in: Cells | 2023

von Soung, Y. | Ju, J. | Chung, J.

9

Cerebellar metastasis of ovarian cancer : a case report

enthalten in: Journal of medical case reports | 2023

von Cabitza, E. | Pirola, M. | Baldessari, C. | +12

10

Hereditary breast and ovarian cancer : from genes to molecular targeted therapies

enthalten in: Critical reviews in clinical laboratory sciences | 2023

von Ponti, G. | De Angelis, C. | Ponti, R. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]